News Orders & Deals JASUB Property Holdings LLP Acquires 1.83% Stake in Cohance Lifesciences LimitedJASUB Property Holdings LLP Acquires 1.83% Stake in Cohance Lifesciences Limited
JASUB Property Holdings LLP acquired 70,00,000 shares (1.83%) of Cohance Lifesciences Limited on February 18, 2026, through inter-se transfer block deals. Combined with persons acting in concert, the group now holds 2,43,26,009 shares representing 6.36% of total share capital. The acquisition was disclosed under SEBI regulations, with the acquirer confirming it is not part of the promoter group.
*this image is generated using AI for illustrative purposes only.
JASUB Property Holdings LLP has acquired a significant stake in Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited, through a substantial share acquisition completed on February 18, 2026. The acquisition has been disclosed under Regulation 29(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares & Takeover) Regulations, 2011.
Acquisition Details
The transaction involved the purchase of 70,00,000 equity shares, representing 1.83% of the total share capital and 1.78% of the diluted share capital of Cohance Lifesciences. The acquisition was executed through inter-se transfer via block deals, marking JASUB Property Holdings LLP's entry as a shareholder in the pharmaceutical company.
| Parameter | Details |
|---|---|
| Shares Acquired | 70,00,000 |
| Percentage of Total Capital | 1.83% |
| Percentage of Diluted Capital | 1.78% |
| Acquisition Date | February 18, 2026 |
| Mode of Acquisition | Inter-se transfer through Block Deals |
Shareholding Pattern Analysis
Prior to this acquisition, JASUB Property Holdings LLP held no shares in Cohance Lifesciences. However, the company operates in concert with several related entities that already held substantial positions in the target company.
Pre-Acquisition Holdings of Persons Acting in Concert
| Entity | Shares Held | Percentage |
|---|---|---|
| Jasti Property and Equity Holdings Private Limited | 2,51,92,957 | 6.59% |
| Mrs. Venkata Subbamma Jasti | 6,000 | Negligible |
| Mr. Venkateswarlu Jasti | 2,000 | Negligible |
| Mrs. Sudharani Jasti | 2,000 | Negligible |
Post-Acquisition Position
Following the completion of this transaction, the combined holding of JASUB Property Holdings LLP and its persons acting in concert stands at 2,43,26,009 shares, representing 6.36% of the total share capital and 6.20% of the diluted share capital.
Current Shareholding Structure
| Shareholder | Current Holdings | Percentage |
|---|---|---|
| JASUB Property Holdings LLP | 70,00,000 | 1.83% |
| Jasti Property and Equity Holdings Private Limited | 1,73,16,009 | 4.53% |
| Other PAC Members | 10,000 | Negligible |
| Total Combined Holding | 2,43,26,009 | 6.36% |
Company Information
Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, is listed on both BSE Limited and National Stock Exchange of India Limited. The company's total equity share capital stands at 38,25,67,140 shares, while the diluted share capital is 39,22,07,995 shares, accounting for potential conversion of outstanding convertible securities.
Regulatory Compliance
The disclosure was filed by V. Lakshmana Rao, Designated Partner of JASUB Property Holdings LLP, in compliance with SEBI regulations governing substantial acquisitions. The acquirer has confirmed that it does not belong to the promoter or promoter group of Cohance Lifesciences Limited. The filing also notes that out of the previously held shares by persons acting in concert, 8,76,948 shares were sold in the open market between September 8, 2025, and January 8, 2026.
Historical Stock Returns for Cohance Lifesciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.08% | -12.93% | -26.88% | -66.82% | -73.67% | -37.81% |
19
